Journal of Clinical and Aesthetic Dermatology - Science of Skin Summit 2025

140—A multi-center clinical evaluation of new postprocedure product integration

2025-10-29 10:06:03

Presenters: Pasquarello J,1 Anderson MB,2

Avey K,3 Barba A,4Cardena G, DeLaGarza A,5 Dodson S,6 Smith LE,7 Haugen N,8Klawitter K,9Frost JM,10Poor D,11Corina K,12Robinson M,13Swendieman J,14Zimmerman E,15Zepponi J16

Affiliations: 1Robertson Cosmetic Center, Middleton, WI; 2Columbus Aesthetic & Plastic Surgery; 3Tailored Aesthetics Medical Spa; 4In the Nude Skincare; 5Glow Skin by Gaby; 6Rumors Wellness MedSpa; 7Belle Ame Aesthetics; 8Aesthetic Nirvana; 9A Glo Spa; 10A Younger You Medical Spa; 11Beyond Skin Aesthetics; 12Le Beau Visage; 13Robertson Cosmetic Center; 14Realm Esthetics; 15Genesis MedSpa; 14Renew Delta Medical Spa

Background: Minimally invasive aesthetic procedures have grown in demand due to their ability to deliver visible results with lowerdowntime. However, even non-ablative procedures can be associated with posttreatment side effects including erythema, skin tightness, increased heat sensation, and social downtime. The original Colorescience® Finishing Touch Protocol® (FTP 1.0 Treatment SPF products) developed and evaluated through a series of published clinical studies, including a multi-center white paper and peer-reviewed publications that established its safety and efficacy across a range of non-ablative treatments and demonstrated improvements in comfort, appearance, and post-treatment confidence across a variety of in-office treatments. (see references for the previous studies) Building upon that foundation, Finishing Touch Protocol® (FTP 2.0 SPF products) reflect updated product use patterns aligned with evolving practice preferences and patient needs.

Objective: This study was conducted to evaluate FTP 2.0 SPF products incorporated into the Finishing Touch Protocol® across a broad range of procedures with updated product combinations for subject efficacy and tolerability as well as investigator ease of use and clinical integration. The original protocol included All Calm® Clinical Redness Corrector SPF 50 and Even Up® Clinical Pigment Perfector® SPF 50 as the SPF options. In this study, newer formulas were evaluated for efficacy and tolerability including Total Protection® Face Shield SPF 50 (Classic, Glow, Bronze, Flex), Total Protection® No-Show™ Mineral Sunscreen SPF 50, Tint du Soleil® SPF 30, and Total Protection® Color Balms SPF 50. This study included the continued use of Total Eye® 3-in-1 Renewal SPF 35, Total Protection® Brush-On Shield® SPF 50, Mineral Corrector Palette SPF 20, Peptide Lip Shine SPF 30, and Hydrating Mist.

Methods: Subjects (n=32) undergoing non-ablative aesthetic treatments which included but not limited to enzyme facials, HydraFacials®, DiamondGlow®, chemical peels, dermal fillers, neuromodulators, fractional laser resurfacing, microneedling, and Intense Pulsed Light (IPL) therapy, were enrolled across 17 centers. Immediately post-procedure, subjects evaluated their physical sensation and visible appearance prior to FTP 2.0 SPF product application. After the in-clinic application of the full FTP 2.0 SPF product regimen, subjects re-evaluated their appearance and comfort. Follow-up safety and satisfaction assessments were conducted at 48 hours and 5 days post-procedure. Investigators also completed structured evaluations regarding ease of use, education, subject outcomes, and clinical integration.

Results: Investigator Results—Clinical Observations Immediately Post Finishing Touch Protocol® Application: 90% of investigators reported the products soothed and improved skin comfort; 95% of investigators reported the products decreased or neutralized postprocedure redness; 100% of investigators reported subjects felt more confident about their appearance. Investigator Ease of Protocol Adoption: 97% of investigators reported the products are easy to apply post-procedure; 100% of investigators reported it was easy to educate subjects on products in the treatment room; 100% of investigators reported that they: Will integrate the Finishing Touch Protocol® 2.0 SPF products into their clinic post-procedure protocol; Will recommend the Finishing Touch Protocol® 2.0 SPF products to fellow aesthetic professionals; Will recommend the Finishing Touch Protocol® 2.0 SPF products for home care.

Subject Results—The top three subject concerns reported immediately postprocedure before the Finishing Touch Protocol® application were erythema/redness, tightness, and heat sensation. Post-treatment application of the FTP 2.0 SPF product regimen resulted in relief across all commonly reported postprocedure symptoms, with varying degrees of improvement. Subjects experienced reductions in erythema, tightness, heat sensation, stinging, burning, and pruritus (itching). The most frequently reported symptoms, erythema, tightness, and heat sensation demonstrated the highest levels of improvement. 97% of subjects agreed or strongly agreed after the immediate application of the Finishing Touch Protocol® 2.0 SPF products they were more confident about their skin’s appearance. 83% of subjects reported after the immediate application of the Finishing Touch Protocol® 2.0 SPF products they would assume their normal daily activities.

At 48 hours post-procedure and with continued home use of the Finishing Touch Protocol® 2.0 SPF products: 96% of subjects felt confident about their skin’s appearance and 92% reported their skin appearance and feel would not limit daily activities.

At the conclusion of 5 days post-procedure and with continued home use of the Finishing Touch Protocol® 2.0 SPF products 97% of subjects were: Likely to rebook their treatment; would recommend Finishing Touch Protocol® 2.0 SPF products to others; would continue using the products at home.

Conclusion: This multi-center evaluation confirms that the FTP 2.0 SPF products offer a safe, effective, and well-tolerated solution for immediate application following a wide range of non-ablative aesthetic procedures. The updated Finishing Touch Protocol® maintains the integrity and patient-centered goals of the original, while reflecting evolving product preferences and innovations in multifunctional sun protection and cosmetic skin recovery. Across both clinical observations and subjectreported outcomes, FTP 2.0 SPF products demonstrated measurable improvements in post- procedure comfort, confidence, and willingness to resume daily activities. These findings reinforce that the Colorescience® Finishing Touch Protocol® remains a clinically proven and professionally endorsed approach to supporting optimal post- procedure outcomes.

References:

1 Jones IT, Guiha I, Fabi SG. Open-label study assessing the efficacy and tolerability of topical skincare and sun protection products following intense pulsed light treatment. J Cosmet Dermatol. 2017;1–7.

2 Deaver JP, Katz TM. Open-label study assessing the efficacy and tolerability of topical skin care and sun protection alone and in combination with intense pulsed light therapy. J Cosmet Dermatol. 2019;1–7.

3 Grieshaber E, Glorioso A. An Open-label Study Assessing the Efficacy and Tolerability of a Post-treatment Skincare Protocol Following Radiofrequency Microneedling for Facial Rejuvenation. J Clin Aesthet Dermatol. 2022;15(5):12–18.

4 Colorescience®. Finishing Touch Protocol® White Paper. Carlsbad, CA: Colorescience, Inc.; June 2018.

©Matrix Medical Communications. View All Articles.

140—A multi-center clinical evaluation of new postprocedure product integration
https://jcad.mydigitalpublication.com/articles/140-a-multi-center-clinical-evaluation-of-new-postprocedure-product-integration

Menu
  • Page View
  • Contents View
  • Issue List
  • Advertisers
  • Website

Issue List

March 2026

Hot Topics in Alopecia February 2026

February 2026

January 2026

Chronic Hand Eczema: Understanding a Complex and Persistent Inflammatory Disease

December 2025

Hot Topics in Alopecia November 2025

Science of Skin Summit 2025

Hot Topics in Melanoma November 2025

November 2025

October 2025

September 2025

Hot Topics in Alopecia Areata August 2025

August 2025

July 2025

Hot Topics in Melanoma July 2025

June 2025

Hot Topics in Pigmented Lesions May 2025

May 2025

April 2025

Hot Topics in Melanoma April 2025

March 2025

February 2025

January 2025

December 2024 Supplement 3

Dermatology Conference Highlights 2024

December 2024

November 2024

Hot Topics in Melanoma November 2024

October 2024

September 2024 Supplement 2

September 2024

August 2024

July 2024

Hot Topics in Squamous Cell Carcinoma July 2024

June 2024

May 2024 Supplement 2

May 2024

April 2024

Hot Topics in Psoriasis March 2024

March 2024

Supplement - March 2024

Hot Topics in Psoriasis February 2024

February 2024

January 2024

Supplement - December 2023

December 2023

Supplement - December 2023

Vitiligo Conference Highlights: November 2023

November 2023

Supplement - November 2023

Supplement - October 2023

October 2023

Hot Topics in Melanoma October 2023

Supplement - September 2023

September 2023

Hot Topics in Skin Health September 2023

Supplement - August 2023

August 2023

Hot Topics in Melanoma August 2023

Hot Topics in Skin Health July 2023

Hot Topics in Psoriasis July 2023

Hot Topics in Psoriasis June 2023

Hot Topics in Skin Health May 2023


Library